Cosmo Pharmaceuticals N.V. (0RGI)
Market Closed
15 Oct, 03:30 PM
51. 80
CHF +2.1
+4.2254%
- Market Cap
104.48 P/E Ratio
8% Div Yield
8,159 Volume
0 Eps
49.7 CHF
Previous Close Want to track 0RGI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cosmo Pharmaceuticals N.V. (0RGI) Statistics
Valuation metrics
Market Cap -
Enterprise value 923.02M
Trailing P/E (ttm) -145.36
Forward P/E -
PEG ratio 1.42
Price/Sales (ttm) 9.25
Price/Book (mrq) 1.66
Enterprise Value/Revenue 8.99
Enterprise Value/EBITDA -1,449.51
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 940
Average volume (90 days) 6.16K
Price summary
52-Week low 49.2
52-Week high 129.6
Beta -
50-Day moving average 55.13
200-Day moving average 68.81
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 2.1
Trailing annual dividend yield 0.038%
5-Year annual dividend yield -
Payout ratio -6.93
Dividend Date 11 May 2026
Ex-Dividend Date 24 Apr 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.06%
Operating margin -0.13%
Operational effectiveness
Return on assets -0.01%
Return on equity -0.01%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 6.03
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.37
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 11.46
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 10.66%
Book value per share (mrq) 33.66
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
